Lakefront Biotherapeutics NV (LKFT)

LKFT Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	488.78	320.88	74.08	211.7	-217.99	-103.23
Depreciation & Amortization	36.81	36.81	38.33	43.64	65.57	16.24
Other Amortization	3.79	3.79	5.92	-	-	5.07
Loss (Gain) From Sale of Assets	-1.06	-1.06	-52.48	-1.09	-0.02	-
Asset Writedown & Restructuring Costs	243.39	243.39	1.24	-	-	13.33
Loss (Gain) From Sale of Investments	50.74	50.74	-49.98	-22.3	-6.93	4.8
Stock-Based Compensation	24	24	17.69	36.63	88.51	70.73
Provision & Write-off of Bad Debts	-9.64	-9.64	9.64	-	-	-
Other Operating Activities	-170.21	-2.5	-46.12	-2.2	-50.2	-58.18
Change in Accounts Receivable	86.59	86.59	-31.06	-39.11	68.98	79.86
Change in Inventory	28.85	28.85	23.04	-24.08	-34.59	-21.17
Change in Unearned Revenue	-1,012	-1,071	-255.51	-661.06	-383.62	-453.72
Change in Other Net Operating Assets	-71.67	32.02	-57.03	31.82	-30.25	-35.35
Operating Cash Flow	-301.6	-257.46	-320.03	-405.97	-500.54	-503.83
Capital Expenditures	-8.73	-13.7	-16.72	-18.71	-27.39	-54.21
Sale of Property, Plant & Equipment	1.78	0.46	0	2.43	0.74	-
Cash Acquisitions	-	-	-	-7	-115.27	-
Divestitures	-10.15	19.43	-8.95	-	-	28.7
Sale (Purchase) of Intangibles	-	-0.16	-65.39	-0.57	-9.56	-3.67
Investment in Securities	221.61	219.59	282.16	80.27	-1,087	570.41
Other Investing Activities	81.06	83.19	29.5	14.77	-7	0.01
Investing Cash Flow	265.57	288.81	220.6	71.19	-1,246	541.24
Long-Term Debt Repaid	-	-3.27	-4.92	-6.77	-8.18	-7.19
Net Debt Issued (Repaid)	-2.77	-3.27	-4.92	-6.77	-8.18	-7.19
Issuance of Common Stock	-	-	-	1.77	6.7	3.31
Financing Cash Flow	-2.77	-3.27	-4.92	-5	-1.49	-3.88
Foreign Exchange Rate Adjustments	-2.46	-4.46	1.78	-1.52	22.29	56.76
Miscellaneous Cash Flow Adjustments	-	-	-	-	0	-0
Net Cash Flow	-41.26	23.63	-102.57	-341.31	-1,725	90.3
Free Cash Flow	-310.33	-271.16	-336.75	-424.68	-527.93	-558.03
Free Cash Flow Margin	-29.73%	-24.38%	-122.16%	-177.15%	-218.83%	-238.09%
Free Cash Flow Per Share	-4.71	-4.12	-5.11	-6.44	-8.04	-8.52
Cash Interest Paid	0.46	0.46	0.69	3.81	12.46	12.54
Cash Income Tax Paid	0.37	0.37	-0.41	8.17	4.43	0.68
Levered Free Cash Flow	210.97	344.64	-274.43	-119.36	-23.64	-119.32
Unlevered Free Cash Flow	211.21	345.29	-273.86	-118.26	-19.34	-112.07
Change in Working Capital	-968.19	-923.86	-320.55	-692.44	-379.47	-430.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.